Technical rejection remains a common and costly issue in regulatory submissions for clinical trials. Many submissions fail before scientific review begins, leading to avoidable delays, rework, and pressure on development timelines. For teams focused on timely study start-up and approvals, passing technical validation first time is essential. In this context, the FDA’s Technical Rejection Criteria (TRC) are automated checks applied to certain study data submission components during inbound processing and can lead to a ‘technical rejection’ before a regulator begins content review.
This article explores why regulatory submissions fail technical rejection criteria and how these failures can be avoided. The focus is on technical and procedural issues, not scientific or benefit–risk assessment.
What is the Technical Rejection Criteria for Study Data?
The technical rejection criteria are the practical ‘pass/fail’ checks that confirm a submission is complete, correctly structured, and technically usable by the receiving authority. For FDA study data, this includes TRC checks that help confirm required study data is present and valid (for example, required datasets and a valid define.xml), so the package can be processed and reviewed.
In practice, TRC-style checks are designed to surface structural and compliance issues early, so teams can correct and resubmit rather than carrying defects into downstream review workflows.
Where Does the Technical Rejection Criteria Apply in the eCTD?
TRC checks do not apply equally to every file in a submission. They are applied to specific eCTD locations and study data ‘contexts’ (for example, where clinical study datasets and their metadata are placed), which is why a submission can look complete overall but still fail study data technical validation.
This matters for planning and publishing because teams need to ensure the right content is in the right place, with the expected metadata and technical artefacts.
What Typically Causes Technical Rejection Criteria Failures?
eCTD Structure and Formatting Issues
Problems with the electronic Common Technical Document (eCTD) remain a leading cause of technical rejection. Typical issues include:
- Incorrect folder structures
- Missing or invalid XML backbones
- Broken or incorrect hyperlinks
- File naming or placement errors
These issues can prevent regulators from navigating the submission correctly.
Study Data and Metadata Issues
Study data problems frequently trigger technical rejection, even when analyses are otherwise sound. Common causes include:
- Errors in Study Tagging Files
- Dataset formatting inconsistencies
- Non-compliance with required data standards
- Incomplete or inconsistent metadata
Small inconsistencies can have a disproportionate impact during technical validation.
Missing or Inconsistent Documentation
Submissions may also fail when required documents are missing or inconsistent, such as:
- Omitted appendices or supporting files
- Version mismatches between documents
- Inconsistent terminology across modules
These issues often reflect weaknesses in document control rather than isolated mistakes.
Failure to Meet Authority-Specific Criteria
Technical requirements are not identical across regulators. Criteria applied by the FDA may differ from those used by the EMA or other authorities. A submission that passes validation in one region may still fail in another if local requirements are not met, particularly for study data and metadata. The practical implication is that ‘one-size-fits-all’ publishing checklists can miss authority-specific validation rules and portal constraints.
Common FDA Technical Rejection Criteria Failure Points for Study Data
FDA technical rejection criteria points often come down to missing, invalid, or inconsistently tagged study data artefacts that prevent the package from being processed as intended.
For example, the FDA requires the presence of:
- The Demographics dataset (DM) for SDTM submissions
- The Subject-Level Analysis Dataset (ADSL) for ADaM submissions
- The Trial Summary dataset (TS)
- A valid define.xml file (for a PDF substitute, and not renamed)
Dataset Naming and Structure
Certain datasets must be submitted using exact naming conventions. For example:
- The SDTM Trial Summary dataset must be submitted as ts.xpt. Variations such as ts_xpt.xpt are not considered valid. The TS dataset is expected regardless of the standard used, so it is worth treating as a baseline technical requirement.
- The same principle applies to dm.xpt (SDTM) and adsl.xpt (ADaM).
- Incorrect naming alone is enough to cause a dataset to fail technical validation.
STUDYID and Study Tagging File Consistency
The STUDYID variable in the TS dataset must match the <study-id> value in the Study Tagging File (stf.xml). If these values do not match, the TS dataset is not considered valid, even if all other content is correct.
Trial Summary Content Requirements
Within the SDTM TS dataset, required parameters must be populated correctly. For example:
- The Study Start Date (TSPARMCD="SSTDTC") must be present.
- The associated value must be a valid ISO 8601 date.
Missing or invalid values will cause the TS dataset to fail technical criteria. It is also worth budgeting time for TS content: teams often underestimate the effort to research, confirm, and populate it correctly.
How Can Teams Reduce Technical Rejection Criteria Risk Before Submission?
Project Planning
Many technical rejections can be traced back to early planning decisions rather than late-stage errors. A clear plan helps teams build the right controls into the workflow. A practical addition is to treat TRC as a pre-flight requirement and run staged validation gates during build, packaging, and final publishing, rather than relying on a single end-stage check.
Define Objectives Early
Defining objectives is one of the most important steps in submission planning. Teams should agree early on:
- The submission type and target authority
- Applicable technical standards and guidance
- What 'submission-ready' means for the project
Clear objectives help align expectations and reduce rework. Where available, teams can also use FDA-aligned self-check resources (for example, TRC-focused checklists or worksheets) to confirm expectations before final submission assembly.
Assign Roles and Responsibilities
Everyone involved in the project should have clearly defined responsibilities. This includes ownership for:
- Data standards compliance
- Validation activities
- Final technical sign-off
When roles are unclear, gaps and duplication become more likely. For complex submissions, it can help to formalise a cross-functional review model (for example, standards, programming, publishing, and submission operations) so validator findings and package contents are reviewed consistently before upload.
Build Realistic Timelines
Timelines should allow sufficient time for internal checks, reconciliation, and final validation. Rushed finalisation increases the risk of errors that only surface during technical review. Build time for iterative validation outputs (not just the final pass), so issues are corrected while teams still have context and access to source artefacts.
Follow Current Guidance
To reduce validation errors, teams should understand and follow current guidance for submitting study data, including the Study Data Technical Conformance Guide. In practice, teams often need to align multiple layers of checks (eCTD publishing validation, authority business rules, and study validator rules), and confirm they are using the right rule sets for the submission type and timing.
How Should Teams Handle Rejection Criteria Risk When There are Multiple Data Packages?
Multiple data packages in a single submission such as interim and final locks or multiple studies supporting a programme can increase TRC risk because it is easier to misplace content, mix metadata, or lose traceability across folders and outputs.
Practical controls that can help include agreeing early what each package represents and how it will be referenced across the submission as well as maintaining clear, consistent foldering and naming so reviewers can distinguish packages without ambiguity.
Conclusion
In practice, failures commonly trace back to repeatable issues including packaging/publishing defects, missing or misnamed datasets, and misaligned metadata. Clear ownership, authority-specific checklists, and staged validation gates can reduce rework and protect timelines
Quanticate's statistical programming team can support with CDISC mapping, SDTM/ADaM preparation, define.xml, Study Tagging File alignment, and submission-ready dataset packages. Request a consultation and a member of our team will be in touch.
